https://gilead.com

Gilead SciencesGilead Sciences, biopharmaceutical company, Gilead pharmaceuticals, Gilead Pipeline, Gilead sciences research and development, Liver Diseases, pharma companies, biotech companies, biopharma clinical trials,  Gilead patient assistance program, gilead hiv drugs, Gilead investor relations, gilead clinical trials, gilead hiv treatment, oncology pharma company Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.Gilead Sciences Science Science Therapeutic Areas Therapeutic Areas Virology Virology HIV Viral Hepatitis COVID-19 and Emerging Viruses Oncology Inflammation Pipeline Research Research Our R&D Approach Research Funding Programs Research Funding Programs Scholars Program External-Sponsored Research External-Sponsored Research Virology RFP Opportunities Oncology RFP Opportunities Inflammation RFP Opportunities Community-Based Participatory Research Research Publications Clinical Trials Diversity in Clinical Trials Medicines Medicines Patient Safety Patient Safety Anti-Counterfeiting Consumer Product Safety Report an Adverse Event Medication Access Medication Access U.S. Patient Access Managed Access Authorized Distributors Responsibility Responsibility ESG ESG ESG Performance ESG Focus Areas ESG Frameworks and Reporting Sustainability Sustainability Sustainability Focus Areas Health Equity Giving@Gilead Giving@Gilead Corporate Giving Corporate Giving Strategic Initiatives Strategic Initiatives All4Liver Asia Pacific Rainbow Grant COMPASS Initiative HepConnect HIV Age Positively RADIAN Setting the P.A.C.E.- Prevention, Arts and Advocacy, Community, Education Toward Health Equity Oncology Grant Toward Health Equity for Black People Impacted by TNBC TRANScend Zeroing In: Ending the HIV Epidemic How to Apply for Funding How to Apply for Funding Giving in Africa Giving in Asia Giving in Australia Giving in Europe & the Middle East Giving in Latin America & the Caribbean Giving in North America Gilead Foundation Gilead Foundation Creating Possible Fund Building Community Donations Global Health and Access Global Health and Access FOCUS Access in Low- and Middle-Income Countries Access in Low- and Middle-Income Countries Invasive Fungal Infections Access Partnerships Inclusion and Diversity Inclusion and Diversity Employee Resource Groups Employee Resource Groups GAIN Gileados GLOBE GVET Pride Alliance Women at Gilead Medical Education Stories Company Company Leadership View All Leaders Daniel O’Day Andrew Dickinson Stacey Ma Flavius Martin, MD Jyoti Mehra Johanna Mercier Merdad Parsey, MD, PhD Cindy Perettie Deborah H. Telman Board of Directors View All Directors Daniel O’Day Jacqueline K. Barton, PhD Jeffrey A. Bluestone, PhD Sandra J. Horning, MD Kelly A. Kramer Ted W. Love, MD Harish Manwani Javier J. Rodriguez Anthony Welters Board Governance and Committees Company Statements Ethics and Compliance Policies Disclosures U.S. Public Policy Engagement U.S. Public Policy Engagement Political Contributions Archives Supplier Information Supplier Information Supplier Enablement Resources: SAP Ariba Supplier Inclusion Annual & ESG Reports U.S. Locations Careers Careers Life at Gilead Life at Gilead Inclusion and Diversity in Hiring Opportunities Opportunities Early Career Opportunities Early Career Opportunities Gilead Internship Program Postdoctoral fellowships Global Workforce News Investors Search Search Hamber ACHIEVING BOLD AMBITIONS For more than 35 years, we've been tackling some of the world’s greatest public health challenges, revolutionizing HIV treatment and prevention and delivering a cure for hepatitis C. Now, we're working to discover and advance therapies that offer new hope to patients impacted by diseases across our therapeutic areas of Virology, Oncology and Inflammation. Delivering Transformative Therapies and Advancing Health Equity  Through innovation, we’re helping to build a healthier world for all people. Learn More About Gilead 25+ Medicines Offered Globally 52 Clinical Programs Across Virology, Oncology and Inflammation #1 Philanthropic Funder of HIV-Related Programs Using Science to Improve the Lives of People and Communities We invest in world-class science to combat the world's most devastating diseases. Explore Science A Strong Pipeline Spanning Three Therapeutic Areas We have a deep, diverse pipeline across Virology, Oncology and Inflammation. View Our Pipeline Virology Oncology Inflammation View All Therapeutic Areas   Stories@GileadFollow our journey to create a healthier world for all peopleScientific InnovationWorking to Build Next-Generation Cancer TherapiesSeptember 10, 2024Access and Health EquityChampioning HIV Services for LGBTQ+ YouthSeptember 05, 2024Access and Health EquityLiving with a Rare Liver Disease: Maria’s JourneyAugust 23, 2024Access and Health EquityBuilding a Bridge to a Healthier World for Youth in AfricaAugust 06, 2024Access and Health EquityClosing the HIV Diagnosis Gap in GermanyJuly 25, 2024 View Stories@Gilead An Inclusive Workplace Where We All Can Make an Impact More than 18,000 employees at Gilead worldwide work to advance scientific innovation, help ensure our medicines reach those who need it and make a difference in the communities where we live and work. Explore Careers at Gilead NewsSome of the content on this page is not intended for users outside the U.S. View News Investors Driven by Purpose, Delivering Life-Changing Therapies Resources for Investors Investor Relations Events and Presentations Stock Information This is our global website, intended for visitors seeking information on Gilead’s worldwide business. Some content on this site is not intended for people outside the United States. Visit our Global Operations page for links to our international corporate websites. QUICK LINKS Investors Find a Trial Our Pipeline Search for Jobs News Stories@Gilead GET IN TOUCH Contact Us Report an Adverse Event Medical Information Partnership Request LEGAL Modern Slavery Act Statement Public Policy Engagement Social Media Guidelines Privacy Statement Terms of Use Cookie Statement © 1996-2024 Gilead Sciences, Inc. All rights reserved. Global Site Sitemapenen1726783814https://gilead.com